daytrading nov 13 afternoon, page-85

Nihl I agree to me ISN does look overvalued at $120m+ market cap but I might be missing something about it

I keep thinking about that "I'm not smarter than the market" line

While I don't expect ALT to mimic ISNs run from 5c to 80c or $12m to $180m+ I can see a situation where prior to any PeriCoach revenue ALT moves up considerably from these historic lows its always stayed at

The 2 stand out things for me are combining Bio Tech and Mobile App and the reoccurring revenue stream from subscriptions vs one off sales from a product